Skip to Main Content

Paper Details

PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia.
Leukemia
6
2022
Author NameAffiliation
Daniel J ColemanKnight Cancer Institute, Oregon Health & Science University
Joseph EstabrookKnight Cancer Institute, Oregon Health & Science University
Joseph EstabrookCancer Early Detection Advanced Research Center, Oregon Health & Science University
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerOregon Health & Science University
Brian J DrukerOregon Health & Science University
Julia E MaxsonKnight Cancer Institute, Oregon Health & Science University
Julia E MaxsonOregon Health & Science University
Julia E MaxsonOregon Health & Science University
Julia E MaxsonOregon Health & Science University
Theodore P BraunKnight Cancer Institute, Oregon Health & Science University
Theodore P BraunOregon Health & Science University
Theodore P BraunOregon Health & Science University
  • 1 - 13

Datasets

Release 1.2